Updates are available Correction dated 2022-05-05
Click to view Correction: https://doi.org/10.1038/s41375-022-01588-z
-
Authors
Adamia, Sophia http://orcid.org/0000-0001-5704-6040
Bhatt, Shruti
Wen, Kenneth
Chyra, Zuzana
Fell, Geoffrey G.
Tai, Yu-Tzu http://orcid.org/0000-0001-6199-3569
Pioso, Marisa S.
Abiatari, Ivane
Letai, Anthony http://orcid.org/0000-0002-1993-9013
Dorfman, David M.
Hideshima, Teru
Anderson, Kenneth C. http://orcid.org/0000-0002-6418-0886
- License Information
-
More Information
Article History
Received: 1 June 2021
Revised: 4 November 2021
Accepted: 10 November 2021
First Online: 27 January 2022
Change Date: 5 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41375-022-01588-z
Competing interests
: The research was supported by a collaborative grant from Eli Lilly. The authors declare no competing financial interests related to this work. KCA is an advisor of Janssen, Amgen, Pfizer, Precision Biosciences, Mana, and Raqia; and is a Scientific Founder of OncoPrep and C4 Therapeutics.
